These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 18086475)
1. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475 [TBL] [Abstract][Full Text] [Related]
2. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia. Alladi CG; RajKumar RP; Adithan S; Marie-Claire C; Bellivier F; Shewade DG Fundam Clin Pharmacol; 2019 Jun; 33(3):355-364. PubMed ID: 30332506 [TBL] [Abstract][Full Text] [Related]
3. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Gunes A; Scordo MG; Jaanson P; Dahl ML Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980 [TBL] [Abstract][Full Text] [Related]
4. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342 [TBL] [Abstract][Full Text] [Related]
5. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine. Gunes A; Melkersson KI; Scordo MG; Dahl ML J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110 [TBL] [Abstract][Full Text] [Related]
6. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study). Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225 [TBL] [Abstract][Full Text] [Related]
7. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676 [TBL] [Abstract][Full Text] [Related]
8. Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India. Kaur G; Gupta D; Chavan BS; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J Asian J Psychiatr; 2017 Oct; 29():174-182. PubMed ID: 28692863 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine. Tybura P; Trześniowska-Drukała B; Bienkowski P; Beszlej A; Frydecka D; Mierzejewski P; Samochowiec A; Grzywacz A; Samochowiec J Psychiatry Res; 2014 Oct; 219(2):261-7. PubMed ID: 24930580 [TBL] [Abstract][Full Text] [Related]
10. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs. Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023 [TBL] [Abstract][Full Text] [Related]
11. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604 [TBL] [Abstract][Full Text] [Related]
12. Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. Kuzman MR; Medved V; Bozina N; Grubišin J; Jovanovic N; Sertic J Pharmacogenomics J; 2011 Feb; 11(1):35-44. PubMed ID: 20195292 [TBL] [Abstract][Full Text] [Related]
13. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
15. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia. Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Laika B; Leucht S; Heres S; Schneider H; Steimer W Pharmacogenomics J; 2010 Feb; 10(1):20-9. PubMed ID: 19636338 [TBL] [Abstract][Full Text] [Related]
17. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157 [TBL] [Abstract][Full Text] [Related]
18. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients. Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547 [TBL] [Abstract][Full Text] [Related]
19. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine. Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468 [TBL] [Abstract][Full Text] [Related]
20. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain. Popp J; Leucht S; Heres S; Steimer W Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]